Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: A multicenter retrospective cohort
Journal of Internal Medicine · 2024-04 · 295 (4) · 532-543
DOI: 10.1111/joim.13752 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Internal Medicine, online erschienen am 27.11.2023. Verfasst von Kevin Chevalier und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Assistance Publique-Hôpitaux de Par…. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Mixed Connective Tissue Disease. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Objectives
The objective of this study is to better characterize the features and outcomes of a large population of patients with mixed connective tissue disease (MCTD).
Methods
We performed an observational retrospective multicenter cohort study in France. Patients who fulfilled at least one diagnostic criterion set for MCTD and none of the criteria for other differentiated CTD (dCTD) were included.
Results
Three hundred and thirty patients (88% females, median [interquartile range] age of 35 years [26–45]) were included. The diagnostic criteria of Sharp or Kasukawa were met by 97.3% and 93.3% of patients, respectively. None met other classification criteria without fulfilling Sharp or Kasukawa criteria. After a median follow‐up of 8 (3–14) years, 149 (45.2%) patients achieved remission, 92 (27.9%) had interstitial lung disease, 25 (7.6%) had pulmonary hypertension, and 18 (5.6%) died. Eighty‐five (25.8%) patients progressed to a dCTD, mainly systemic sclerosis (15.8%) or systemic lupus erythematosus (10.6%). Median duration between diagnosis and progression to a dCTD was 5 (2–11) years. The presence at MCTD diagnosis of an abnormal pattern on nailfold capillaroscopy (odds ratio [OR] = 2.44, 95% confidence interval [95%CI] [1.11–5.58]) and parotid swelling (OR = 3.86, 95%CI [1.31–11.4]) were statistically associated with progression to a dCTD. Patients who did not progress to a dCTD were more likely to achieve remission at the last follow‐up (51.8% vs. 25.9%).
Conclusions
This study shows that MCTD is a distinct entity that can be classified using either Kasukawa or Sharp criteria, and that only 25.8% of patients progress to a dCTD during follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
- Department of Internal Medicine, Henri-Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Est Créteil (UPEC), Créteil, France.
- Department of Internal Medicine, Nantes University Hospital, University of Nantes, Nantes, France.
- Department of Internal Medicine, Hôpital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
- Department of Rheumatology, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Saclay, Le Kremlin Bicêtre, France.
- Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Pitié-Salpêtrière, Université Paris Sorbonne, Paris, France.
ORCID-Profile: Kevin Chevalier, Benjamin Thoreau, Christian Agard, Karim Sacre, Patrice Cacoub, Benjamin Chaigne
Zitieren
APA
Chevalier, K., Thoreau, B., Michel, M., Godeau, B., Agard, C., Papo, T., Sacre, K., Seror, R., Mariette, X., Cacoub, P., Benhamou, Y., Levesque, H., Goujard, C., Lambotte, O., Bonnotte, B., Samson, M., Ackermann, F., Schmidt, J., Duhaut, P., …, & Mouthon, L. (2024). Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: A multicenter retrospective cohort. Journal of Internal Medicine, 295(4), 532-543. https://doi.org/10.1111/joim.13752
Vancouver
Chevalier K, Thoreau B, Michel M, Godeau B, Agard C, Papo T, et al. Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: A multicenter retrospective cohort. Journal of Internal Medicine. 2024;295(4):532-543. doi:10.1111/joim.13752
BibTeX
@article{Chevalier2024,
author = {Chevalier, Kevin and Thoreau, Benjamin and Michel, Marc and Godeau, Bertrand and Agard, Christian and Papo, Thomas and Sacre, Karim and Seror, Raphaèle and Mariette, Xavier and Cacoub, Patrice and Benhamou, Ygal and Levesque, Hervé and Goujard, Cécile and Lambotte, Olivier and Bonnotte, Bernard and Samson, Maxime and Ackermann, Félix and Schmidt, Jean and Duhaut, Pierre and Kahn, Jean-Emmanuel and Hanslik, Thomas and Costedoat-Chalumeau, Nathalie and Terrier, Benjamin and Regent, Alexis and Dunogue, Bertrand and Cohen, Pascal and Guern, Véronique Le and Hachulla, Eric and Chaigne, Benjamin and Mouthon, Luc},
title = {Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: A multicenter retrospective cohort},
journal = {Journal of Internal Medicine},
year = {2024},
volume = {295},
number = {4},
pages = {532--543},
doi = {10.1111/joim.13752}
}
EUVIMED